Could the Obama plan to regulate the VC industry in the US, provide a big boost to the Israeli VC industry? Sure could be the case. With Obama trying to regulate everything that has a smell of money, the VC industry could be in for trouble. That means opportunity for Israel. this means that the new Netanyahu government must cut taxes across the board and especially corporate taxes, that will help spur job growth and entrepreneurism.
Batya Feldman of Globes has an interesting interview with some local VC players. An an interview with Benchmark’s Michael Eisenberg: “Opposition to the rules being drafted is to be found in Israel as well. Michael Eisenberg, partner at VC firm Benchmark Capital, takes issue with the intention to impose the regulations on the world of venture capital.
“Geithner spoke of the need for regulation of anything that could become a substantial threat to the economy,” he says, “and I don’t see how a venture capital fund could represent a threat to the entire financial system. But we can relax. Regulation will apply to venture capital finds that will be put together in the future, so no problems are expected for funds that have already raised capital.”
How far will the new rules affect Israel’s high-tech industry?
“It’s hard to know what the regulation will consist of. If there’s a requirement to report on every investment, that will be impossible. However, for Israel this is in fact a once in a lifetime opportunity, one that could make it a world financial center. If they impose restrictions on the funds in the US, in Israel we should give incentives, loans and insurance that will encourage funds to register in Israel. That way we won’t be the carriage but the locomotive.
We here about the demise of the Israeli VC industry. Maybe Israel can capitalize on Obama’s mistake and not only save the VC industry, but have it both flourish here and attract foreign funds as well.
Written by: Aaron Katsman | December 22, 2008
What would you say if I told you that there was a company that developed GPS-like technology for the human body? You’d probably say that that is really cool. Well leave it to Israeli ingenuity and creativity to create such a cutting-edge technology. In fact it’s such an interesting technology that St. Jude Medical(STJ) has bought the Israeli company for $300m.
In a market with very little M&A, this makes 2 acquisitions of Israeli companies in as many months. Johnson & Johnson(JNJ) bought Omrix Biopharmaceuticals(OMRI) as well. This shows that multi-nationals would rather outsource their R&D than develop it in-house. if this trend continues, it could get very interesting for Israeli hi-tech.
MediGuide was founded in 2000 by Gera Strommer, president and CEO, and Uzi Eichler, vice president technology, as a spin-off from Elbit Systems (Nasdaq: ESLT), which owns 41.3% of the company, and with backing from Israeli venture capital fund Vitalife.
According to Globes: “MediGuide has developed technology and products for minimally invasive navigation and tracking within the human body. Its devices are for use in cardiac procedures and catheterization. The system consists of sensors mounted on a catheter introduced into the body, with the locating done on the basis of the distance of the sensors from several sources of magnetic radiation, with an accuracy of fractions of a millimeter.
The information from the sensors is combined with an image of the interior of the body, in a way that is similar to the way locating using a GPS device works. Since in catheterization or other invasive procedure, the human body undergoes changes, the device measures physiological indications from the body breathing, EKG, and so on and amends the picture accordingly.”
What will they think of next?
Please see our Disclaimer HERE.
Aaron Katsman is Managing Editor of the Israel Opportunity Investor newsletter. He is lead portfolio manager for the Israel Growth Portfolio and Managing Director of America Israel Investment Associates, LLC. For more information, go to www.israelnewsletter.com or call 1-888-327-6179, or email aaron@profile-financial.com.